Home > Pharmacy > Other > Volume-6 > Issue-3 > A Review on Atopic Dermatitis: Etiology, Clinical Features, Pathogenesis, Diagnosis, and Various Treatments

A Review on Atopic Dermatitis: Etiology, Clinical Features, Pathogenesis, Diagnosis, and Various Treatments

Call for Papers

Volume-8 | Issue-3

Last date : 26-Jun-2024

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


A Review on Atopic Dermatitis: Etiology, Clinical Features, Pathogenesis, Diagnosis, and Various Treatments


Jayaprakash U | Preethi T | C. J. Glady Gloria Grant



Jayaprakash U | Preethi T | C. J. Glady Gloria Grant "A Review on Atopic Dermatitis: Etiology, Clinical Features, Pathogenesis, Diagnosis, and Various Treatments" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3, April 2022, pp.1476-1487, URL: https://www.ijtsrd.com/papers/ijtsrd49758.pdf

Atopic dermatitis is a recurrent, chronic inflammatory skin disease which affects children. Dermatitis is derived from the Greek words "derma" (skin) and "itis" (inflammation). It affects 10-20% of adolescents and 1-3 percent of adults over their lifetime are caused by a complicated interaction between relevant genes, the environment of the host, pharmacological aberrations, and immunological variables. Two primary theories have been postulated. The first theory is that the adaptive immune system is out of balance, and the second is that the skin barrier is impaired. There is no specific test for Atopic dermatitis. Topical or systemic treatments are indicated depending on the severity of the Atopic dermatitis. It includes emmolients, corticosteroids, calcineurin inhibitors, phosphodiesterase 4 inhibitors, biological and wet wrap therapy. Once remission has been achieved, proactive maintenance therapy should be used to limit the number of flare-ups.

Atopic Dermatitis, Filaggrin, Flare-ups, Human monoclonal antibody


IJTSRD49758
Volume-6 | Issue-3, April 2022
1476-1487
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin